PUBLIC SECTOR PENSION INVESTMENT BOARD - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 175 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC SECTOR PENSION INVESTMENT BOARD ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$419,000
-41.8%
330,0520.0%0.00%
-50.0%
Q3 2021$720,000
-41.8%
330,0520.0%0.00%
-42.9%
Q2 2021$1,238,000
+26.2%
330,052
+9.7%
0.01%
+16.7%
Q1 2021$981,000
-10.8%
300,862
-6.7%
0.01%
-25.0%
Q4 2020$1,100,000
-16.4%
322,6320.0%0.01%
-27.3%
Q3 2020$1,316,000
+53.9%
322,632
+27.5%
0.01%
+37.5%
Q2 2020$855,000
+44.9%
253,0520.0%0.01%
+14.3%
Q1 2020$590,000
-35.9%
253,0520.0%0.01%
+16.7%
Q4 2019$921,000
-61.2%
253,052
-11.7%
0.01%
-62.5%
Q3 2019$2,376,000
+17.6%
286,452
+22.1%
0.02%0.0%
Q2 2019$2,020,000
+102.4%
234,600
+151.2%
0.02%
+77.8%
Q1 2019$998,000
+31.5%
93,400
+7.7%
0.01%
+50.0%
Q4 2018$759,000
-34.1%
86,700
+26.6%
0.01%
-25.0%
Q3 2018$1,151,000
-9.5%
68,500
+12.9%
0.01%
-11.1%
Q2 2018$1,272,000
+35.0%
60,676
+3.6%
0.01%
+28.6%
Q1 2018$942,000
-45.8%
58,576
-36.2%
0.01%
-36.4%
Q4 2017$1,739,000
+162.7%
91,776
+95.0%
0.01%
+266.7%
Q3 2017$662,000
+143.4%
47,076
+28.8%
0.00%
+50.0%
Q2 2017$272,000
-16.0%
36,550
-26.7%
0.00%
-33.3%
Q1 2017$324,000
+46.6%
49,8500.0%0.00%
+50.0%
Q4 2016$221,000
-5.2%
49,8500.0%0.00%0.0%
Q3 2016$233,000
-13.1%
49,850
+22.0%
0.00%
-33.3%
Q2 2016$268,000
+3.1%
40,8500.0%0.00%0.0%
Q1 2016$260,000
+5.7%
40,8500.0%0.00%
+50.0%
Q4 2015$246,000
-36.9%
40,850
-37.4%
0.00%
-33.3%
Q3 2015$390,000
-36.7%
65,250
-27.5%
0.00%
-25.0%
Q2 2015$616,000
-7.1%
90,050
-17.5%
0.00%
-20.0%
Q1 2015$663,000
-11.8%
109,150
+0.6%
0.01%0.0%
Q4 2014$752,000
-14.8%
108,4760.0%0.01%
-16.7%
Q3 2014$883,000
-9.8%
108,476
-9.9%
0.01%0.0%
Q2 2014$979,000
+12.8%
120,376
+8.8%
0.01%0.0%
Q1 2014$868,000
-24.9%
110,675
-15.3%
0.01%
-14.3%
Q4 2013$1,156,000
+7.7%
130,675
+2.2%
0.01%0.0%
Q3 2013$1,073,000
+45.4%
127,875
+29.3%
0.01%
+16.7%
Q2 2013$738,00098,8750.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders